What is an aromatase inhibitor (AI)?

An aromatase inhibitor (AI) is a class of medication that blocks the enzyme aromatase, which naturally converts testosterone into estradiol (a form of estrogen). Common AIs used in TRT protocols include anastrozole (Arimidex) and letrozole (Femara). By inhibiting this conversion, AIs help prevent excess estradiol accumulation that can occur when men receive testosterone replacement.

In Miami FL and elsewhere, some TRT providers prescribe AIs alongside testosterone therapy to manage estrogen-related side effects. These may include gynecomastia (breast tissue growth), water retention, or mood changes. The goal is to maintain estradiol levels within a target range rather than suppress them completely, since some estrogen is necessary for bone health, cardiovascular function, and sexual function.

Whether an AI is warranted depends on individual response to testosterone dosing, baseline estradiol levels, and clinical presentation. Not all TRT patients require an AI; some achieve adequate hormone balance through testosterone dosing alone. When prescribed, AIs are typically used at lower doses than those given for breast cancer treatment, and dosing is adjusted based on follow-up lab work and patient symptoms.

If you are considering TRT and want to discuss AI protocols, qualified TRT providers in Miami can evaluate whether an aromatase inhibitor is appropriate for your individual needs.